Kevin Cognetti joined Kite in 2020 and currently serves as Vice President of Corporate Strategy and Planning.
Prior to joining Kite, Kevin held positions of increasing responsibility at Pfizer, including Vice President of Global Strategy for the Upjohn Division. During his tenure there, Kevin spearheaded the integration planning team for a $500M rare disease licensing deal and developed the strategy and operating model for Pfizer's pivot to five core therapeutic areas. Before Pfizer, Kevin worked at McKinsey & Company, where he collaborated with Fortune 500 corporations on various growth and cost reduction strategies.
Kevin received his bachelor’s degree, JD and MBA from Georgetown University.
Executive Vice President, Kite
Global Public Affairs (Interim)